# EDGAR Filing Document

**Accession Number:** 0001209466
**File Stem:** 0001209466-25-000625
**Filing Date:** 2025-12
**Character Count:** 15944
**Document Hash:** d64335942235c6776b75edca86eb62f7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209466-25-000625.hdr.sgml**: 20251229

**ACCESSION NUMBER**: 0001209466-25-000625

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251031

**FILED AS OF DATE**: 20251229

**DATE AS OF CHANGE**: 20251229

**PERIOD START**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INVESCO EXCHANGE-TRADED FUND TRUST
- **CENTRAL INDEX KEY:** 0001209466

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21265
- **FILM NUMBER:** 251604234

**BUSINESS ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 800-983-0903

**MAIL ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POWERSHARES EXCHANGE TRADED FUND TRUST
- **DATE OF NAME CHANGE:** 20021210

## Series and Classes Contracts Data

### Invesco Pharmaceuticals ETF (Series ID: S000003031)

| Class ID   | Class Name                  | Ticker Symbol   |
|:---|:---|:---|
| C000008298 | Invesco Pharmaceuticals ETF | PJP             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Invesco Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-21265

- **c. CIK number of Registrant:** 0001209466

- **d. LEI of Registrant:** QPT4TMG79RF3UWNU0R52

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3500 Lacey Road

  - **City:** Downers Grove

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60515

  - **Telephone number:** 800-983-0903

**Item A.2. Information about the Series.**

- **a. Name of Series:** Invesco Pharmaceuticals ETF

- **b. EDGAR series identifier (if any):** S000003031

- **c. LEI of Series:** 549300SCARFWCQZS8C10

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-04-30

- **b. Date as of which information is reported:** 2025-10-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $318009787.83

**Total Liabilities:** $41072571.82

**Net Assets:** $276937216.01

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000008298 | 12.69%               | 1.80%                | 4.62%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $439808.50               | $28748745.12                               |
| Month 2  | $5730317.88              | $-1119153.43                               |
| Month 3  | $117508.51               | $11972918.91                               |

### Schedule of Portfolio Investments

| Name                                  | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Collegium Pharmaceutical, Inc.        | Collegium Pharmaceutical, Inc.                             | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |    183673 | NS      | $6612228.00   | 2.39%             |  |  |  | No            |                  1 | On Loan: —       |
| Corcept Therapeutics Inc.             | Corcept Therapeutics Inc.                                  | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |    101787 | NS      | $7478290.89   | 2.70%             |  |  |  | No            |                  1 | On Loan: —       |
| Ligand Pharmaceuticals Inc.           | Ligand Pharmaceuticals Inc.                                | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     44325 | NS      | $8479815.75   | 3.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Amphastar Pharmaceuticals, Inc.       | Amphastar Pharmaceuticals, Inc.                            | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |    233399 | NS      | $5951674.50   | 2.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Perrigo Co. PLC                       | Perrigo Co. PLC                                            | CUSIP: G97822103<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    298412 | NS      | $6189064.88   | 2.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly and Co.                     | Eli Lilly and Co.                                          | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     17638 | NS      | $15219124.68  | 5.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co.              | Bristol-Myers Squibb Co.                                   | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    149996 | NS      | $6910315.72   | 2.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.       | Regeneron Pharmaceuticals, Inc.                            | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     12050 | NS      | $7854190.00   | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences, Inc.                 | Gilead Sciences, Inc.                                      | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    113136 | NS      | $13552561.44  | 4.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC              | Jazz Pharmaceuticals PLC                                   | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     56650 | NS      | $7797306.00   | 2.82%             |  |  |  | No            |                  1 | On Loan: —       |
| Prestige Consumer Healthcare Inc.     | Prestige Consumer Healthcare Inc.                          | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    106630 | NS      | $6461778.00   | 2.33%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc.                           | AbbVie Inc.                                                | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     62307 | NS      | $13585418.28  | 4.91%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb, Inc.                          | OmniAb, Inc., Rts., expiring 2027-11-02                    | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39023 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: —       |
| ANI Pharmaceuticals, Inc.             | ANI Pharmaceuticals, Inc.                                  | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |     77063 | NS      | $6981907.80   | 2.52%             |  |  |  | No            |                  1 | On Loan: —       |
| United Therapeutics Corp.             | United Therapeutics Corp.                                  | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     22900 | NS      | $10200347.00  | 3.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc.                           | Biogen Inc.                                                | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     51794 | NS      | $7990260.38   | 2.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics, Inc.            | Travere Therapeutics, Inc.                                 | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    406038 | NS      | $14276296.08  | 5.16%             |  |  |  | No            |                  1 | On Loan: —       |
| Ocular Therapeutix, Inc.              | Ocular Therapeutix, Inc.                                   | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |    575482 | NS      | $6710120.12   | 2.42%             |  |  |  | No            |                  1 | On Loan: —       |
| Merck & Co., Inc.                     | Merck & Co., Inc.                                          | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    152752 | NS      | $13133616.96  | 4.74%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb, Inc.                          | OmniAb, Inc., Rts., 2027-11-02                             | CUSIP: 68218J202<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     39023 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: —       |
| Invesco Private Prime Fund            | Invesco Private Prime Fund                                 | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  29413887 | NS      | $29413886.52  | 10.62%            |  |  |  | No            |                  2 | On Loan: No      |
| Pacira Biosciences, Inc.              | Pacira Biosciences, Inc.                                   | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    272462 | NS      | $5825237.56   | 2.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Amgen Inc.                            | Amgen Inc.                                                 | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     44831 | NS      | $13378915.33  | 4.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Avadel Pharmaceuticals PLC            | Avadel Pharmaceuticals PLC                                 | CUSIP: G29687103<br>LEI: 549300E27PTSG2RHC762 | Long             | EC               | CORP              | IE        |    476856 | NS      | $9007809.84   | 3.25%             |  |  |  | No            |                  1 | On Loan: —       |
| Innoviva, Inc.                        | Innoviva, Inc.                                             | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |    355309 | NS      | $6466623.80   | 2.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Harmony Biosciences Holdings, Inc.    | Harmony Biosciences Holdings, Inc.                         | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    190511 | NS      | $5442899.27   | 1.97%             |  |  |  | No            |                  1 | On Loan: —       |
| Viatris Inc.                          | Viatris Inc.                                               | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    680241 | NS      | $7047296.76   | 2.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio, Institutional Class | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |    293772 | NS      | $293772.32    | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                     | Johnson & Johnson                                          | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     73559 | NS      | $13893088.33  | 5.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc.                           | Pfizer Inc.                                                | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    520962 | NS      | $12841713.30  | 4.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals, Inc.        | Supernus Pharmaceuticals, Inc.                             | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |    159777 | NS      | $8808506.01   | 3.18%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Private Government Fund       | Invesco Private Government Fund                            | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  11302086 | NS      | $11302086.08  | 4.08%             |  |  |  | No            |                  2 | On Loan: No      |
| Tarsus Pharmaceuticals, Inc.          | Tarsus Pharmaceuticals, Inc.                               | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    120328 | NS      | $8279769.68   | 2.99%             |  |  |  | No            |                  1 | On Loan: —       |
| Amneal Pharmaceuticals, Inc.          | Amneal Pharmaceuticals, Inc.                               | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |    754936 | NS      | $8168407.52   | 2.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                   | Abbott Laboratories                                        | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |     98658 | NS      | $12196101.96  | 4.40%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-11-30

**Name of Applicant:** Invesco Exchange-Traded Fund Trust

**Signature:** Adrien Deberghes

**Name of Signer:** Adrien Deberghes

**Title:** Vice President